Full Name
Eng King Tan
Variants
Tan, E.-K.
Tan, E.K.
 
 
 
Email
gmstek@nus.edu.sg
 

Refined By:
Subject:  LRRK2

Results 1-16 of 16 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
12007Analysis of LRRK2 Gly2385Arg genetic variant in non-Chinese AsiansTan E.-K. ; Zhao Y.; Tan L. ; Lim H.-Q.; Lee J.; Yuen Y.; Pavanni R.; Wong M.-C.; Fook-Chong S.; Liu J.-J.
2Apr-2011Association of GWAS loci with PD in ChinaChang, X.-L.; Mao, X.-Y.; Li, H.-H.; Zhang, J.-H.; Li, N.-N.; Burgunder, J.-M.; Peng, R.; Tan, E.-K. 
32018Case-control analysis of leucine-rich repeat kinase 2 protective variants in Alzheimer's diseaseNg A.S.L. ; Ng E.Y.L.; Tan Y.J. ; Kandiah N. ; Zhou J. ; Hameed S. ; Ting S.K.S. ; Tan E.-K. 
42008Essential tremor and the common LRRK2 G2385R variantTan E.-K. ; Lee J.; Lim H.-Q. ; Yuen Y.; Zhao Y.
52017Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter studyWang L.; Heckman M.G.; Aasly J.O.; Annesi G.; Bozi M.; Chung S.J.; Clarke C.; Crosiers D.; Eckstein G.; Garraux G.; Hadjigeorgiou G.M.; Hattori N.; Jeon B.; Kim Y.J.; Kubo M.; Lesage S.; Lin J.J.; Lynch T.; Lichtner P.; Mellick G.D.; Mok V.; Morrison K.E.; Quattrone A.; Satake W.; Silburn P.A.; Stefanis L.; Stockton J.D.; Tan E.K. ; Toda T.; Brice A.; Van Broeckhoven C.; Uitti R.J.; Wirdefeldt K.; Wszolek Z.; Xiromerisiou G.; Maraganore D.M.; Gasser T.; Krüger R.; Farrer M.J.; Ross O.A.; Sharma M.
6Aug-2012Genetic analysis of LRRK2 A419V variant in ethnic ChineseLi, N.-N.; Tan, E.-K. ; Chang, X.-L.; Mao, X.-Y.; Zhang, J.-H.; Zhao, D.-M.; Liao, Q.; Peng, R.
72014Genetic testing of LRRK2 in Parkinson's disease: Is there a clinical role?Buhat D.M.L.; Tan E.-K. 
82015Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese populationYu W.-J.; Cheng L.; Li N.-N.; Wang L.; Tan E.-K. ; Peng R.
92009LRRK2 in Parkinson's disease: Genetic and clinical studies from patientsKumari U.; Tan E.K. 
10Nov-2011LRRK2 variant associated with Alzheimer's diseaseZhao, Y.; Ho, P.; Yih, Y.; Chen, C.; Lee, W.L.; Tan, E.K. 
11May-2010Multiple LRRK2 variants modulate risk of Parkinson disease: A Chinese multicenter studyTan, E.-K. ; Peng, R.; Teo, Y.-Y. ; Tan, L.C.; Angeles, D.; Ho, P.; Chen, M.-L.; Lin, C.-H.; Mao, X.-Y.; Chang, X.-L.; Prakash, K.M.; Liu, J.-J.; Au, W.-L.; Le, W.-D.; Jankovic, J.; Burgunder, J.-M.; Zhao, Y.; Wu, R.-M.
12Dec-2011Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal deathAngeles, D.C.; Gan, B.-H.; Onstead, L.; Zhao, Y.; Lim, K.-L.; Dachsel, J.; Melrose, H.; Farrer, M.; Wszolek, Z.K.; Dickson, D.W.; Tan, E.-K. 
132008Pathogenicity of LRRK2 P755L variant in Parkinson's diseaseTan E.-K. ; Lim H.-Q.; Yuen Y.; Zhao Y.
142013Targeting leucine-rich repeat kinase 2 in Parkinson's diseaseChan S.L.; Angeles D.C.; Tan E.-K. 
152017Targeting LRRK2 in Parkinson's disease: an update on recent developmentsChan S.L.; Tan E.-K. 
162005The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patientsTan E.K. ; Shen H.; Tan L.C.S. ; Farrer M.; Yew K.; Chua E.; Jamora R.D.; Puvan K. ; Puong K.Y.; Zhao Y.; Pavanni R. ; Wong M.C. ; Yih Y.; Skipper L.; Liu J.-J.